← FDA Drug Approvals (Drugs@FDA)

INVANZ

NDA · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2001-11-21

Drug application

FDA Application #

NDA021337

Application type

New Drug Application

Brand name

INVANZ

Generic name

ERTAPENEM SODIUM

Active ingredients

ERTAPENEM SODIUM

Dosage form

INJECTABLE

Route

INTRAMUSCULAR, INTRAVENOUS

Marketing status

Prescription

Sponsor

MSD SUB MERCK

Manufacturer

ENDO USA, Inc.

First approval

2001-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown